Diagonal Bio AB (publ) operates as a biotechnology company in Sweden. The company offers LAMPlify, a customized system for general laboratory use to identify the presence of specific genetic markers for, for example, fungi, viruses, or bacteria. It is also involved in the development of PANVIRAL, a universal in vitro diagnostic system, that offers the potential for rapid and accurate point-of-care diagnoses in various settings, such as doctor’s office, surgery, mobile clinics, hospital bedsides, and workplaces and airports. The company was incorporated in 2020 and is based in Lund, Sweden.
| Metrics to compare | DIABIO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDIABIOPeersSector | |
|---|---|---|---|---|
| P/E Ratio | −0.9x | −19.3x | −0.7x | |
| PEG Ratio | −0.02 | −0.36 | 0.00 | |
| Price/Book | 0.3x | 10.2x | 2.6x | |
| Price / LTM Sales | 6.0x | 50.9x | 3.4x | |
| Upside (Analyst Target) | - | 41.2% | 40.0% | |
| Fair Value Upside | Unlock | −4.2% | 6.9% | Unlock |